This is a new guideline from NICE on end of life care. You may have heard it widely reported in the news, given all the attention over the Liverpool Care Pathway. What was reported as being different was the focus on communication with the patient and delivering an ‘individualised’ approach. This is really the biggest part of this guideline. There wasn’t much different in terms of medications advised, or other management.
If you want a bit of a revision of symptom management, then I would strongly advise a read of the guideline, but skip down to 1.4…
I’ll summarise things I felt were different or that I wasn’t fully aware of.
